Soluble Glycoprotein Is Not Required for Ebola Virus Virulence in Guinea Pigs

Thomas Hoenen, Andrea Marzi, Dana P. Scott, Friederike Feldmann, Julie Callison, David Safronetz, Hideki Ebihara, Heinz Feldmann

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Ebola virus (EBOV) uses transcriptional editing to express several glycoproteins (GPs), including secreted soluble GP (sGP) and structural GP1,2, from a single gene. Recombinant viruses predominantly expressing GP1,2 are known to rapidly mutate and acquire an editing site predominantly expressing sGP in vivo, suggesting an important role of this protein during infection. Therefore, we generated a recombinant virus that is no longer able to express sGP and assessed its virulence in the EBOV Guinea pig model. Surprisingly, although this virus remained genetically stable, it did not show any significant attenuation in vivo, showing that sGP is not required for virulence in this model.

Original languageEnglish (US)
Pages (from-to)S242-S246
JournalJournal of Infectious Diseases
Volume212
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

Ebolavirus
Virulence
Glycoproteins
Guinea Pigs
Viruses
Infection
Genes
Proteins

Keywords

  • ebola virus
  • Guinea pigs
  • mRNA editing
  • recombinant virus
  • reverse genetics
  • sGP
  • soluble glycoprotein
  • virulence

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Cite this

Hoenen, T., Marzi, A., Scott, D. P., Feldmann, F., Callison, J., Safronetz, D., ... Feldmann, H. (2015). Soluble Glycoprotein Is Not Required for Ebola Virus Virulence in Guinea Pigs. Journal of Infectious Diseases, 212, S242-S246. https://doi.org/10.1093/infdis/jiv111

Soluble Glycoprotein Is Not Required for Ebola Virus Virulence in Guinea Pigs. / Hoenen, Thomas; Marzi, Andrea; Scott, Dana P.; Feldmann, Friederike; Callison, Julie; Safronetz, David; Ebihara, Hideki; Feldmann, Heinz.

In: Journal of Infectious Diseases, Vol. 212, 01.01.2015, p. S242-S246.

Research output: Contribution to journalArticle

Hoenen, T, Marzi, A, Scott, DP, Feldmann, F, Callison, J, Safronetz, D, Ebihara, H & Feldmann, H 2015, 'Soluble Glycoprotein Is Not Required for Ebola Virus Virulence in Guinea Pigs', Journal of Infectious Diseases, vol. 212, pp. S242-S246. https://doi.org/10.1093/infdis/jiv111
Hoenen T, Marzi A, Scott DP, Feldmann F, Callison J, Safronetz D et al. Soluble Glycoprotein Is Not Required for Ebola Virus Virulence in Guinea Pigs. Journal of Infectious Diseases. 2015 Jan 1;212:S242-S246. https://doi.org/10.1093/infdis/jiv111
Hoenen, Thomas ; Marzi, Andrea ; Scott, Dana P. ; Feldmann, Friederike ; Callison, Julie ; Safronetz, David ; Ebihara, Hideki ; Feldmann, Heinz. / Soluble Glycoprotein Is Not Required for Ebola Virus Virulence in Guinea Pigs. In: Journal of Infectious Diseases. 2015 ; Vol. 212. pp. S242-S246.
@article{7eb1b3d185ac4c2aafa8de0a5dfa00cb,
title = "Soluble Glycoprotein Is Not Required for Ebola Virus Virulence in Guinea Pigs",
abstract = "Ebola virus (EBOV) uses transcriptional editing to express several glycoproteins (GPs), including secreted soluble GP (sGP) and structural GP1,2, from a single gene. Recombinant viruses predominantly expressing GP1,2 are known to rapidly mutate and acquire an editing site predominantly expressing sGP in vivo, suggesting an important role of this protein during infection. Therefore, we generated a recombinant virus that is no longer able to express sGP and assessed its virulence in the EBOV Guinea pig model. Surprisingly, although this virus remained genetically stable, it did not show any significant attenuation in vivo, showing that sGP is not required for virulence in this model.",
keywords = "ebola virus, Guinea pigs, mRNA editing, recombinant virus, reverse genetics, sGP, soluble glycoprotein, virulence",
author = "Thomas Hoenen and Andrea Marzi and Scott, {Dana P.} and Friederike Feldmann and Julie Callison and David Safronetz and Hideki Ebihara and Heinz Feldmann",
year = "2015",
month = "1",
day = "1",
doi = "10.1093/infdis/jiv111",
language = "English (US)",
volume = "212",
pages = "S242--S246",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",

}

TY - JOUR

T1 - Soluble Glycoprotein Is Not Required for Ebola Virus Virulence in Guinea Pigs

AU - Hoenen, Thomas

AU - Marzi, Andrea

AU - Scott, Dana P.

AU - Feldmann, Friederike

AU - Callison, Julie

AU - Safronetz, David

AU - Ebihara, Hideki

AU - Feldmann, Heinz

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Ebola virus (EBOV) uses transcriptional editing to express several glycoproteins (GPs), including secreted soluble GP (sGP) and structural GP1,2, from a single gene. Recombinant viruses predominantly expressing GP1,2 are known to rapidly mutate and acquire an editing site predominantly expressing sGP in vivo, suggesting an important role of this protein during infection. Therefore, we generated a recombinant virus that is no longer able to express sGP and assessed its virulence in the EBOV Guinea pig model. Surprisingly, although this virus remained genetically stable, it did not show any significant attenuation in vivo, showing that sGP is not required for virulence in this model.

AB - Ebola virus (EBOV) uses transcriptional editing to express several glycoproteins (GPs), including secreted soluble GP (sGP) and structural GP1,2, from a single gene. Recombinant viruses predominantly expressing GP1,2 are known to rapidly mutate and acquire an editing site predominantly expressing sGP in vivo, suggesting an important role of this protein during infection. Therefore, we generated a recombinant virus that is no longer able to express sGP and assessed its virulence in the EBOV Guinea pig model. Surprisingly, although this virus remained genetically stable, it did not show any significant attenuation in vivo, showing that sGP is not required for virulence in this model.

KW - ebola virus

KW - Guinea pigs

KW - mRNA editing

KW - recombinant virus

KW - reverse genetics

KW - sGP

KW - soluble glycoprotein

KW - virulence

UR - http://www.scopus.com/inward/record.url?scp=84942862617&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942862617&partnerID=8YFLogxK

U2 - 10.1093/infdis/jiv111

DO - 10.1093/infdis/jiv111

M3 - Article

C2 - 25957965

AN - SCOPUS:84942862617

VL - 212

SP - S242-S246

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

ER -